Proteos Revenue and Competitors
Estimated Revenue & Valuation
- Proteos's estimated annual revenue is currently $3.4M per year.
- Proteos's estimated revenue per employee is $155,000
Employee Data
- Proteos has 22 Employees.
- Proteos grew their employee count by 5% last year.
Proteos's People
Name | Title | Email/Phone |
---|---|---|
1 | President and Chief Scientific Officer | Reveal Email/Phone |
2 | Scientist, Cell Biology | Reveal Email/Phone |
3 | Controller | Reveal Email/Phone |
Proteos Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $1.9M | 12 | 0% | N/A | N/A |
#2 | $2.6M | 34 | -56% | $31.2M | N/A |
#3 | $0.8M | 5 | -44% | N/A | N/A |
#4 | $1.9M | 24 | 100% | N/A | N/A |
#5 | $6M | 39 | -11% | N/A | N/A |
#6 | $4M | 26 | -33% | N/A | N/A |
#7 | $1.9M | 12 | 0% | N/A | N/A |
#8 | $0.8M | 5 | 25% | N/A | N/A |
#9 | $14.6M | 94 | 8% | N/A | N/A |
#10 | $3.4M | 22 | 5% | N/A | N/A |
What Is Proteos?
Proteos is committed to providing a quality foundation for drug discovery. We are a contract research organization that provides the highest quality recombinant protein expression and purification services for drug discovery research in the biotechnology and pharmaceutical industries. Our highly-skilled team of scientists utilizes diverse experience and optimized methods within a customized workflow that focuses on the end product from square one. Fully customized experimental designs allow flexibility and adaptation during the project, thus enabling data-driven decisions that lead to a higher probability of project success. Proteos is passionate about drug discovery. We know that reliable reagents are critical for the ultimate success of drug discovery programs.
keywords:N/AN/A
Total Funding
22
Number of Employees
$3.4M
Revenue (est)
5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $4.2M | 22 | -19% | N/A |
#2 | $4M | 23 | -4% | N/A |
#3 | $3.5M | 24 | -4% | N/A |
#4 | $6.2M | 25 | 0% | N/A |
#5 | N/A | 25 | 0% | N/A |